What is Eosinophils?
Eosinophils are granulocytes — white blood cells containing granules filled with inflammatory mediators — and normally make up 1–4% of the total leukocyte count. In absolute numbers, most laboratories define eosinophilia at counts above 0.5 ×10⁹/L; values above 1.5 ×10⁹/L are classified as hypereosinophilia and warrant further evaluation. Eosinophils are produced in the bone marrow, travel via the blood, and reside longest in tissues — particularly the lungs, gut, and skin. Eosinophil granules contain potent proteins including major basic protein and eosinophil peroxidase, which can kill parasites but also cause tissue damage when chronically activated. That explains both their protective role in parasitic infections and the injury they inflict in sustained allergic or eosinophilic inflammatory diseases such as allergic asthma, eosinophilic oesophagitis, and eosinophilic granulomatosis with polyangiitis (EGPA). Eosinophils can rise with allergic conditions or certain infections. Interpretation always involves the total leukocyte count, the full differential, symptoms, and context — an isolated value without that surrounding information says very little.
Why is Eosinophils relevant?
Eosinophils are clinically relevant because they reflect an immune system responding to specific stimuli: allergens, parasites, and — at higher counts — sometimes autoimmune or haematological conditions. In mild to moderate eosinophilia (0.5–1.5 ×10⁹/L), allergic diseases are the most common cause: asthma, allergic rhinitis, atopic eczema, food allergy, and drug reactions (DRESS syndrome). Parasitic infections — especially tissue-invasive ones such as Toxocara, Strongyloides, and filariasis — classically produce pronounced eosinophilia, more so than luminal gut parasites. At counts above 1.5 ×10⁹/L the differential broadens: hypereosinophilic syndrome, eosinophilic granulomatosis with polyangiitis, malignant haematological disorders (including eosinophilic leukaemia), and paraneoplastic reactions all enter the picture. Organ damage from eosinophils — affecting the heart (Löffler endocarditis), lungs, or nervous system — can occur when hypereosinophilia persists and is a reason for faster diagnostic workup. For people with chronic allergic symptoms or asthma that responds poorly to treatment, the absolute eosinophil count adds meaningful context. A single measurement in a person without symptoms is often not informative enough; a pattern across repeated measurements or the combination with matching symptoms is what gives the value clinical meaning.
Eosinophils high or low — what it means
Eosinophils are almost never interpreted in isolation — the percentage and absolute count within the full leukocyte differential says more than a standalone value. Always look at the rest of the count: an isolated eosinophilia with otherwise normal leukocytes and no symptoms calls for repeat testing and context, not immediate action. A mild elevation (0.5–1.0 ×10⁹/L) in someone with known allergies or during the hay fever season is almost always non-concerning. With targeted symptoms — attacks of asthma or wheezing, a persistent skin rash, gastrointestinal complaints, or features consistent with parasitic exposure (travel to tropical regions, animal contact) — a raised eosinophil count gains immediate clinical weight. Total IgE and specific allergen or parasitic serology are logical add-on tests in that context. At counts above 1.5 ×10⁹/L confirmed on two measurements, further haematological and immunological investigation is warranted. Trends across repeat measurements help separate a transient reaction from a persistent pattern. Because eosinophils are sensitive to corticosteroids — both endogenous (stress) and exogenous (prednisone) — a measurement taken just after a steroid course or during an intense stress period can make the value look artificially low.
Educational information only — not medical advice. Consult a healthcare professional for clinical decisions.
Read about our scientific approach →